The purpose of this randomized double-blind cross-over study was to investigate whether a low-dosed pulsed low-frequency magnetic field or a high-dosed pulsed low-frequency magnetic field improves the cutaneous microcirculation and alters the temperature of the foot. Twelve healthy subjects (five women, seven men) aged on average 25.8 years participated in the trial. Based on a randomization list, one of the following three interventions was applied for 30 min through a cushion placed below the non-dominant foot: either a pulsed low-dosed magnetic field (100 uT, basic frequency 30 Hz with a frequency modulation) or a pulsed high-dosed magnetic field (8.4 mT, 10 Hz), or sham treatment. The individual treatment sessions were applied in intervals of one week, at the same time of the day. Cutaneous microcirculation (laser Doppler flowmetry) and temperature (infra-red thermovision) were measured in the dorsum of the foot and the great toe every 5 min during the intervention, and 5 and 10 min post-intervention. With both pulsed low-dosed magnetic field and pulsed high-dosed magnetic field, just as with the sham treatment, a minor drop in temperature and decrease in microcirculation took place. A two-way repeated-measures analysis of variance revealed no significant difference between the interventions for any parameter. It was concluded that a local application of a pulsed low-frequency magnetic field to the foot did not enhance temperature or cutaneous microcirculation in healthy subjects.

RT-PCR is the gold standard in the diagnosis of COVID-19 infections, due to its high specificity. However, there are clinical situations in which chest CT may prove vital, for example in patients with high clinical and epidemiologic suspicion towards COVID-19 before positive RT-PCR conversion or in detecting complications. Researchers have developed scales that, based on the findings in chest CT, help predict the severity of the disease. There are three main pathologic patterns of lung injury that correlate with the duration of COVID-19 symptoms. Epithelial pattern with diffuse alveolar damage and desquamation/reactive hyperplasia of pneumocytes; vascular pattern with capillary congestion and (micro)thrombi and fibrotic pattern with interstitial fibrous changes. The epithelial pattern and vascular pattern appear early, even before the symptoms of the disease, whereas the fibrous pattern appears approximately three weeks after the onset of the disease. Typical findings on chest CT in COVID-19 infection are: GGO, consolidation, GGO mixed with consolidation, interlobular septal thickening, air bronchogram sign, crazy paving, bronchial wall thickening and vascular enlargement. Findings that may suggest a different etiology include multiple nodules, tree-in-bud opacities, bronchiectasis, pleural and pericardial effusion, extensive consolidations.